0 XP   0   0   0

2Seventy Bio Inc
Buy, Hold or Sell?

I guess you are interested in 2Seventy Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse 2Seventy Bio Inc

Let's start. I'm going to help you getting a better view of 2Seventy Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is 2Seventy Bio Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how 2Seventy Bio Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value 2Seventy Bio Inc. The closing price on 2022-09-30 was $14.55 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
2Seventy Bio Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of 2Seventy Bio Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit 2Seventy Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare 2Seventy Bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -570.7% means that $-5.71 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of 2Seventy Bio Inc:

  • The MRQ is -574.2%. The company is making a huge loss. -2
  • The TTM is -570.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-574.2%TTM-570.7%-3.5%
TTM-570.7%YOY-761.5%+190.7%
TTM-570.7%5Y-666.1%+95.4%
5Y-666.1%10Y-666.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-574.2%-241.1%-333.1%
TTM-570.7%-275.9%-294.8%
YOY-761.5%-342.1%-419.4%
5Y-666.1%-475.7%-190.4%
10Y-666.1%-561.7%-104.4%
1.1.2. Return on Assets

Shows how efficient 2Seventy Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare 2Seventy Bio Inc to the Biotechnology industry mean.
  • -14.8% Return on Assets means that 2Seventy Bio Inc generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of 2Seventy Bio Inc:

  • The MRQ is -9.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-14.8%+4.9%
TTM-14.8%YOY-20.0%+5.3%
TTM-14.8%5Y-17.4%+2.6%
5Y-17.4%10Y-17.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%-9.7%-0.1%
TTM-14.8%-8.7%-6.1%
YOY-20.0%-9.2%-10.8%
5Y-17.4%-11.5%-5.9%
10Y-17.4%-12.4%-5.0%
1.1.3. Return on Equity

Shows how efficient 2Seventy Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare 2Seventy Bio Inc to the Biotechnology industry mean.
  • -20.4% Return on Equity means the company generated $-0.20 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of 2Seventy Bio Inc:

  • The MRQ is -20.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.4%TTM-14.1%-6.3%
TTM-14.1%YOY-98.1%+84.0%
TTM-14.1%5Y-56.1%+42.0%
5Y-56.1%10Y-56.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.4%-11.8%-8.6%
TTM-14.1%-11.0%-3.1%
YOY-98.1%-10.6%-87.5%
5Y-56.1%-13.5%-42.6%
10Y-56.1%-14.5%-41.6%

1.2. Operating Efficiency of 2Seventy Bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient 2Seventy Bio Inc is operating .

  • Measures how much profit 2Seventy Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare 2Seventy Bio Inc to the Biotechnology industry mean.
  • An Operating Margin of -572.5% means the company generated $-5.73  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of 2Seventy Bio Inc:

  • The MRQ is -572.5%. The company is operating very inefficient. -2
  • The TTM is -570.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-572.5%TTM-570.7%-1.9%
TTM-570.7%YOY-791.8%+221.1%
TTM-570.7%5Y-681.2%+110.6%
5Y-681.2%10Y-681.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-572.5%-232.1%-340.4%
TTM-570.7%-269.6%-301.1%
YOY-791.8%-309.3%-482.5%
5Y-681.2%-466.7%-214.5%
10Y-681.2%-572.5%-108.7%
1.2.2. Operating Ratio

Measures how efficient 2Seventy Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 670.3% means that the operating costs are $6.70for each $1 in net sales.

Let's take a look of the Operating Ratio trends of 2Seventy Bio Inc:

  • The MRQ is 6.703. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.031. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.703TTM7.031-0.328
TTM7.031YOY9.099-2.068
TTM7.0315Y8.065-1.034
5Y8.06510Y8.0650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7033.321+3.382
TTM7.0313.542+3.489
YOY9.0993.491+5.608
5Y8.0655.744+2.321
10Y8.0657.007+1.058

1.3. Liquidity of 2Seventy Bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if 2Seventy Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 387.7% means the company has $3.88 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of 2Seventy Bio Inc:

  • The MRQ is 3.877. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.918. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.877TTM2.918+0.959
TTM2.918YOY0.255+2.663
TTM2.9185Y1.587+1.332
5Y1.58710Y1.5870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8775.266-1.389
TTM2.9186.060-3.142
YOY0.2556.365-6.110
5Y1.5876.692-5.105
10Y1.5876.457-4.870
1.3.2. Quick Ratio

Measures if 2Seventy Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 462.7% means the company can pay off $4.63 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of 2Seventy Bio Inc:

  • The MRQ is 4.627. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 48.068. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.627TTM48.068-43.441
TTM48.068YOY0.125+47.942
TTM48.0685Y24.096+23.971
5Y24.09610Y24.0960.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6273.985+0.642
TTM48.0684.865+43.203
YOY0.1255.192-5.067
5Y24.0965.275+18.821
10Y24.0964.997+19.099

1.4. Solvency of 2Seventy Bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of 2Seventy Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.52 means that 2Seventy Bio Inc assets are financed with 51.9% credit (debt) and the remaining percentage (100% - 51.9%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of 2Seventy Bio Inc:

  • The MRQ is 0.519. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.706. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.519TTM0.706-0.187
TTM0.706YOY0.591+0.115
TTM0.7065Y0.648+0.058
5Y0.64810Y0.6480.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5190.271+0.248
TTM0.7060.269+0.437
YOY0.5910.296+0.295
5Y0.6480.361+0.287
10Y0.6480.399+0.249
1.4.2. Debt to Equity Ratio

Measures if 2Seventy Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 107.8% means that company has $1.08 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of 2Seventy Bio Inc:

  • The MRQ is 1.078. The company is able to pay all its debts with equity. +1
  • The TTM is 0.773. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.078TTM0.773+0.304
TTM0.773YOY2.904-2.131
TTM0.7735Y1.839-1.065
5Y1.83910Y1.8390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0780.310+0.768
TTM0.7730.311+0.462
YOY2.9040.310+2.594
5Y1.8390.382+1.457
10Y1.8390.438+1.401

2. Market Valuation of 2Seventy Bio Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in 2Seventy Bio Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -1.40 means the investor is paying $-1.40 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of 2Seventy Bio Inc:

  • The EOD is -1.544. Company is losing money. -2
  • The MRQ is -1.400. Company is losing money. -2
  • The TTM is -1.248. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-1.544MRQ-1.400-0.143
MRQ-1.400TTM-1.248-0.152
TTM-1.248YOY--1.248
TTM-1.2485Y-0.624-0.624
5Y-0.62410Y-0.6240.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.544-2.150+0.606
MRQ-1.400-2.332+0.932
TTM-1.248-3.889+2.641
YOY--5.087+5.087
5Y-0.624-3.697+3.073
10Y-0.624-3.390+2.766
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of 2Seventy Bio Inc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of 2Seventy Bio Inc:

  • The MRQ is 0.045. Very good. +2
  • The TTM is 0.045. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.045TTM0.0450.000
TTM0.0455Y0.0450.000
5Y0.04510Y0.0450.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0450.004+0.041
TTM0.0450.019+0.026
5Y0.0450.021+0.024
10Y0.0450.017+0.028

2. Books
2.3. Price to Book Ratio

Measures if the stock price of 2Seventy Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.34 means the investor is paying $1.34 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of 2Seventy Bio Inc:

  • The EOD is 1.474. Good. +1
  • The MRQ is 1.337. Good. +1
  • The TTM is 426.005. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD1.474MRQ1.337+0.137
MRQ1.337TTM426.005-424.668
TTM426.005YOY-+426.005
TTM426.0055Y213.003+213.003
5Y213.00310Y213.0030.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4741.816-0.342
MRQ1.3371.961-0.624
TTM426.0052.789+423.216
YOY-3.538-3.538
5Y213.0032.782+210.221
10Y213.0032.419+210.584

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of 2Seventy Bio Inc.

3.1. Institutions holding 2Seventy Bio Inc

Institutions are holding 93.538% of the shares of 2Seventy Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30EcoR1 Capital, LLC9.23061.5929349594300
2022-06-30Wellington Management Company LLP7.67120.0077290536739341215.6616
2022-06-30State Street Corporation6.57880.0022491623-668353-21.1506
2022-06-30Vanguard Group Inc6.15230.0009233008394975768.8067
2022-06-30Baker Bros Advisors LP5.44640.1545206274400
2022-06-30Armistice Capital, LLC4.22460.36841600000-400000-20
2022-06-30Madison Avenue Partners, LP3.99044.0811151130061432868.4891
2022-06-30Bain Capital Life Sciences Investors, LLC3.722.181140890100
2022-06-30Newtyn Management LLC3.5563.36821346796-241009-15.1788
2022-06-30RTW INVESTMENTS, LLC3.24630.4193122950800
2022-06-30Credit Suisse First Boston (CSFB)2.65720.0138100636219900.1981
2022-06-30CHI Advisors LLC2.16424.132481967200
2022-06-30CAAS CAPITAL MANAGEMENT LP1.8460.4609699136553171378.9751
2022-06-30Geode Capital Management, LLC1.79070.001367819124483556.4974
2022-06-30Casdin Capital, LLC1.62320.686161475400
2022-06-30Millennium Management LLC1.4070.004453287117690949.6988
2022-03-31JPMorgan Chase & Co1.27480.001482807-21997-4.3575
2022-06-30Boxer Capital LLC1.21410.384445983600
2022-06-30Balyasny Asset Management LLC1.20650.01964569347211518.74
2022-03-31Morgan Stanley - Brokerage Accounts1.05190.0009398404282046242.395
Total 70.052217.880826531232  

3.2. Funds holding 2Seventy Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Vanguard Health Care Inv5.40390.0595204666600
2022-08-31SPDR® S&P Biotech ETF4.12260.3131561370-11570-0.7356
2022-07-31Vanguard Total Stock Mkt Idx Inv2.9260.0013110818400
2022-07-31CS (Lux) Digital Health Equity SB USD2.54650.497696444200
2022-08-31iShares Russell 2000 ETF2.16760.0231820963-1296-0.1576
2022-07-31Vanguard Extended Market Index Investor1.4990.0094567736-8234-1.4296
2022-08-31iShares Russell 2000 Value ETF0.98890.045637455000
2022-07-31JPM Thematics Genetic Thrps C2 Acc USD0.87170.3823330129-4579-1.3681
2022-06-30Fidelity® Small Cap Index0.73580.02142786739226549.4963
2022-06-30Vanguard Strategic Equity Inv0.55450.04222100127760058.605
2022-07-31Fidelity® Select Pharmaceuticals Port0.55240.342820920000
2022-08-31State St Russell Sm/Mid Cp® Indx NL Cl C0.53670.009120328600
2022-07-31Fidelity® Extended Market Index0.50680.0086191930-1000-0.5183
2022-08-31Global X Genomics & Biotechnology ETF0.45721.106617314600
2022-08-31Schwab US Small-Cap ETF™0.39280.016214875800
2022-08-31Direxion Daily S&P Biotech Bull 3X ETF0.38760.212714681029762.0691
2022-07-31JPMorgan US Small Company L0.38340.218614521900
2022-06-30LVIP SSgA Small/Mid Cap 200 Std0.36090.428113668000
2022-07-31State St Russell Sm Cap® Indx NL Cl C0.34940.020913234000
2022-07-31Vanguard Health Care ETF0.31720.008812013312951.0897
Total 26.06093.76789870227  

3.3. Insider Transactions

Insiders are holding 1.628% of the shares of 2Seventy Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-05Nick LeschlySELL549916.23545985
2022-08-05Philip D GregorySELL240716.23104388
2022-08-05William D Baird IIISELL415216.2383096
2022-07-15Nick LeschlySELL540413.81551484
2022-07-15Philip D GregorySELL236513.81106795
2022-07-15William D Baird IIISELL408013.8187248
2022-02-07Nicola HeffronSELL163616.01
2022-02-04Nicola HeffronSELL46715.41
2022-01-07Nick LeschlySELL327023.91
2022-01-07Philip D GregorySELL145223.91
2022-01-07William D Baird IIISELL89623.91
2021-12-07Nicola HeffronSELL25731.06

4. Summary

4.1. Key Performance Indicators

The key performance indicators of 2Seventy Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--9.8744.819+105%2.111+368%3.465+185%3.465+185%
Book Value Per Share Growth---2.0201.946-204%0.523-486%1.234-264%1.234-264%
Current Ratio--3.8772.918+33%0.255+1419%1.587+144%1.587+144%
Debt To Asset Ratio--0.5190.706-26%0.591-12%0.648-20%0.648-20%
Debt To Equity Ratio--1.0780.773+39%2.904-63%1.839-41%1.839-41%
Dividend Per Share----0%-0%-0%-0%
Eps---2.017-2.356+17%-3.411+69%-2.884+43%-2.884+43%
Eps Growth---30.923-30.9230%---30.9230%-30.9230%
Gains Per Share---2.0201.946-204%0.523-486%1.234-264%1.234-264%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---5.742-5.707-1%-7.615+33%-6.661+16%-6.661+16%
Operating Margin---5.725-5.7070%-7.918+38%-6.812+19%-6.812+19%
Operating Ratio--6.7037.031-5%9.099-26%8.065-17%8.065-17%
Pb Ratio1.474+9%1.337426.005-100%-+100%213.003-99%213.003-99%
Pe Ratio-1.544-10%-1.400-1.248-11%--100%-0.624-55%-0.624-55%
Peg Ratio--0.0450.0450%--0.0450%0.0450%
Price Per Share14.550+9%13.20013.973-6%-+100%6.986+89%6.986+89%
Quick Ratio--4.62748.068-90%0.125+3595%24.096-81%24.096-81%
Return On Assets---0.098-0.148+50%-0.200+104%-0.174+77%-0.174+77%
Return On Equity---0.204-0.141-31%-0.981+380%-0.561+175%-0.561+175%
 EOD+1 -2MRQTTM+9 -7YOY+12 -45Y+12 -410Y+12 -4

4.2. Fundamental Score

Let's check the fundamental score of 2Seventy Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.544
Price to Book Ratio (EOD)Between0-11.474
Net Profit Margin (MRQ)Greater than0-5.742
Operating Margin (MRQ)Greater than0-5.725
Quick Ratio (MRQ)Greater than14.627
Current Ratio (MRQ)Greater than13.877
Debt to Asset Ratio (MRQ)Less than10.519
Debt to Equity Ratio (MRQ)Less than11.078
Return on Equity (MRQ)Greater than0.15-0.204
Return on Assets (MRQ)Greater than0.05-0.098
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of 2Seventy Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.001
Ma 20Greater thanMa 5014.711
Ma 50Greater thanMa 10015.156
Ma 100Greater thanMa 20013.898
OpenGreater thanClose14.000
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Total Other Income Expense Net 3,8821,3555,23763,07368,310-63,5964,714-5,145-431



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets787,406
Total Liabilities408,422
Total Stockholder Equity378,984
 As reported
Total Liabilities 408,422
Total Stockholder Equity+ 378,984
Total Assets = 787,406

Assets

Total Assets787,406
Total Current Assets383,890
Long-term Assets383,890
Total Current Assets
Cash And Cash Equivalents 269,868
Short-term Investments 88,059
Net Receivables 12,161
Other Current Assets 13,802
Total Current Assets  (as reported)383,890
Total Current Assets  (calculated)383,890
+/-0
Long-term Assets
Property Plant Equipment 304,139
Goodwill 12,056
Long Term Investments 40,639
Intangible Assets 7,656
Other Assets 39,026
Long-term Assets  (as reported)403,516
Long-term Assets  (calculated)403,516
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities99,014
Long-term Liabilities309,408
Total Stockholder Equity378,984
Total Current Liabilities
Short-term Debt 10,730
Accounts payable 6,685
Other Current Liabilities 40,837
Total Current Liabilities  (as reported)99,014
Total Current Liabilities  (calculated)58,252
+/- 40,762
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt265,912
Other Liabilities 43,496
Long-term Liabilities  (as reported)309,408
Long-term Liabilities  (calculated)309,408
+/-0
Total Stockholder Equity
Common Stock4
Retained Earnings -202,625
Accumulated Other Comprehensive Income -3,382
Capital Surplus 584,987
Total Stockholder Equity (as reported)378,984
Total Stockholder Equity (calculated)378,984
+/-0
Other
Capital Stock4
Cash and Short Term Investments 357,927
Common Stock Shares Outstanding 38,381
Common Stock Total Equity4
Current Deferred Revenue40,762
Liabilities and Stockholders Equity 787,406
Net Debt 6,774
Net Invested Capital 378,984
Net Tangible Assets 359,272
Net Working Capital 284,876
Short Long Term Debt Total 276,642



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302019-12-31
> Total Assets 
303,744
0
312,620
0
303,744
192,959
760
851,921
787,406
787,406851,921760192,959303,7440312,6200303,744
   > Total Current Assets 
18,625
25,104
25,104
18,625
18,625
24,595
362
412,799
383,890
383,890412,79936224,59518,62518,62525,10425,10418,625
       Cash And Cash Equivalents 
0
0
0
0
0
0
362
270,893
269,868
269,868270,893362000000
       Short-term Investments 
0
0
0
0
0
0
362
106,973
88,059
88,059106,973362000000
       Net Receivables 
11,370
10,691
10,691
11,370
11,370
16,135
16,995
16,931
12,161
12,16116,93116,99516,13511,37011,37010,69110,69111,370
       Other Current Assets 
7,255
0
14,413
0
7,255
8,460
-362
124,975
13,802
13,802124,975-3628,4607,255014,41307,255
   > Long-term Assets 
285,119
0
287,516
0
285,119
168,364
468
439,122
403,516
403,516439,122468168,364285,1190287,5160285,119
       Property Plant Equipment 
241,379
260,481
260,481
253,944
253,944
139,062
310
35,038
304,139
304,13935,038310139,062253,944253,944260,481260,481241,379
       Goodwill 
13,128
0
13,128
0
13,128
12,056
12
12,056
12,056
12,05612,0561212,05613,128013,128013,128
       Long Term Investments 
0
0
0
0
0
0
97,124
74,683
40,639
40,63974,68397,124000000
       Intangible Assets 
12,127
0
5,644
0
12,127
11,009
10
8,774
7,656
7,6568,7741011,00912,12705,644012,127
       Long-term Assets Other 
18,485
0
8,263
0
5,920
6,237
39
383,254
39,026
39,026383,254396,2375,92008,263018,485
> Total Liabilities 
255,055
0
237,991
0
255,055
251,366
400
404,505
408,422
408,422404,505400251,366255,0550237,9910255,055
   > Total Current Liabilities 
103,783
75,868
75,868
103,783
103,783
106,080
98
106,313
99,014
99,014106,31398106,080103,783103,78375,86875,868103,783
       Short-term Debt 
14,100
0
15,313
0
14,100
14,480
10
0
10,730
10,73001014,48014,100015,313014,100
       Accounts payable 
18,978
7,152
7,152
18,978
18,978
6,197
6
72,122
6,685
6,68572,12266,19718,97818,9787,1527,15218,978
       Other Current Liabilities 
44,943
14,407
52,583
17,407
70,705
85,403
78
34,191
40,837
40,83734,1917885,40370,70517,40752,58314,40744,943
   > Long-term Liabilities 
151,272
0
162,123
0
151,272
145,286
301
298,192
309,408
309,408298,192301145,286151,2720162,1230151,272
       Other Liabilities 
0
49,833
49,833
47,197
47,197
45,467
29,019
28,903
43,496
43,49628,90329,01945,46747,19747,19749,83349,8330
> Total Stockholder Equity
43,692
0
74,629
0
48,689
-58,407
360
447,416
378,984
378,984447,416360-58,40748,689074,629043,692
   Common Stock
0
74,629
74,629
48,689
48,689
-58,407
0
4
4
440-58,40748,68948,68974,62974,6290
   Retained Earnings Total Equity-202,625-125,205-39,494000000
   Accumulated Other Comprehensive Income -3,3820-1000000
   Capital Surplus 
0
0
0
0
0
0
400,026
575,421
584,987
584,987575,421400,026000000
   Treasury Stock000000000
   Other Stockholders Equity 
43,692
0
0
0
0
-58,407
400
-2,804
584,987
584,987-2,804400-58,407000043,692



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue55
Cost of Revenue-3
Gross Profit5252
 
Operating Income (+$)
Gross Profit52
Operating Expense-368
Operating Income-313,948-316
 
Operating Expense (+$)
Research Development262
Selling General Administrative93,506
Selling And Marketing Expenses-
Operating Expense36893,768
 
Net Interest Income (+$)
Interest Income88
Interest Expense-0
Net Interest Income8888
 
Pretax Income (+$)
Operating Income-313,948
Net Interest Income88
Other Non-Operating Income Expenses21,647
Income Before Tax (EBT)-292-627,604
EBIT - interestExpense = -292
-292
-292
Interest Expense0
Earnings Before Interest and Taxes (ebit)-292-292
Earnings Before Interest and Taxes (ebitda)16,058
 
After tax Income (+$)
Income Before Tax-292
Tax Provision-0
Net Income From Continuing Ops-292,213-292
Net Income-292
Net Income Applicable To Common Shares-292,213
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses371
Total Other Income/Expenses Net313,656-21,735
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
RENTBERRY.CC
1 minute ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
3 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
5 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
8 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
14 minutes ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
16 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
16 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
18 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
18 minutes ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
18 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
20 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
20 minutes ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
22 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart
PAK.CC
22 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PAK.CC.

PAK.CC Daily Candlestick Chart
OPCT.CC
24 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of OPCT.CC.

OPCT.CC Daily Candlestick Chart
OK.CC
24 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OK.CC.

OK.CC Daily Candlestick Chart
NXS.CC
26 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of NXS.CC.

NXS.CC Daily Candlestick Chart
NODE.CC
26 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NODE.CC.

NODE.CC Daily Candlestick Chart
NMR.CC
26 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NMR.CC.

NMR.CC Daily Candlestick Chart